Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeSCIEXEPL Bio Analytical Services Selects SCIEX QTRAP 6500+ LC-MS System With SelexION...

EPL Bio Analytical Services Selects SCIEX QTRAP 6500+ LC-MS System With SelexION Differential Mobility Separation Technology Device

SCIEX, (life science analytical technologies), announced today that EPL Bio Analytical Services, (EPL BAS), an agriculture-focused analytical contract laboratory, has selected the SCIEX QTRAP® 6500+ with SelexION®+, enabling their researchers to provide analytical solutions to customers with projects involving difficult matrices that the lab could not previously consider accepting.

EPL’s analytical laboratory provides customized analytical laboratory testing services to the agricultural crop protection, agricultural chemical, agricultural biotechnology, organic, biocontrol, nutritional, food ingredient, and feed industries and they partner with customers from around the world to provide safe and reliable agricultural products to local and global consumers. EPL’s installation of the SCIEX QTRAP 6500+ LC-MS/MS system with multi-component IonDrive™ Technology and a newly designed IonDrive High Energy Detector+, offers them the high sensitivity, reliability and confidence they require to produce data as objective evidence for the efficacy and safety of a wide range agricultural product, including organic products, synthetic chemistry, and plant-incorporated protectants.

The QTRAP 6500+ system delivers enhanced selectivity, without compromising MRM sensitivity, for more flexibility in dealing with complex interferences. The exclusive QTRAP scan function of MS3 (MS/MS/MS), adds an additional level of mass filtering, while the SelexION+ ion mobility provides an orthogonal separation prior to mass separation and offers the lab yet another tool for eliminating isobaric background interferences in complex assays, making quantitation in complex samples easier and less time consuming. The unique scan functions offered by the SCIEX QTRAP system, including enhanced mass scans (EMS), enhanced resolution scans (ER), and enhanced product ion scans (EPI), deliver maximum flexibility and workflow options enabling researchers to embrace new discoveries and more accurate identification that extend beyond quantitation.

“The 6500+ with SelexION allows EPL Bio Analytical Services to have unique product offering and provides a significant competitive advantage that enables their researchers to solve problems other labs cannot,” said Paul Winkler, Food and Beverage Marking Development Manager, Americas at SCIEX. “The acquisition of the QTRAP 6500+ provides EPL Bio Analytical Services with an instrument that has better low mass negative ion performance than their competitors’ laboratories, and with the addition of SelexION, EPL Bio Analytical Services further extends their ability to perform analyses in complex matrices such as environmental and agricultural samples.”

Fred Claussen, VP of Method Development EPL Bio Analytical Services said, “At EPL, the management and staff place a high value on being the industry leader.” Claussen added, “When we find a technology that will provide better data to our customers, we go get it. In the competitive world of contract laboratories, having the best technology, along with the best technical staff allows us to more effectively compete for new business and uphold our strong brand on a global level. We believe that the acquisition of these SCIEX solutions gives our laboratory this important competitive edge.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy